LOGICBIO THERAPEUTICS INC (LOGC)
US54142F1021 - Common Stock
ChartMill assigns a Buy % Consensus number of 78% to LOGC. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 2.3. This target is 10.87% above the current price.
LOGC was analyzed by 10 analysts. The buy percentage consensus is at 78. So analysts seem to be have mildly positive about LOGC.
In the last month the buy percentage fell by 6 points. So the trust of analysts is decreasing.
LOGC was analyzed by 10 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2022-08-22 | Chardan Capital | Maintains | Buy |
| 2022-05-17 | Chardan Capital | Maintains | Buy |
| 2022-05-10 | JMP Securities | Maintains | Market Outperform |
| 2022-02-03 | William Blair | Downgrade | Outperform -> Market Perform |
| 2022-02-02 | Chardan Capital | Maintains | Hold |
| 2021-12-23 | Chardan Capital | Maintains | Buy |
| 2021-11-17 | Barclays | Maintains | Overweight |
| 2021-11-16 | JMP Securities | Maintains | Market Outperform |
| 2021-06-07 | HC Wainwright & Co. | Initiate | Buy |
| 2021-03-04 | JMP Securities | Initiate | Outperform |